JP2014520767A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520767A5 JP2014520767A5 JP2014517492A JP2014517492A JP2014520767A5 JP 2014520767 A5 JP2014520767 A5 JP 2014520767A5 JP 2014517492 A JP2014517492 A JP 2014517492A JP 2014517492 A JP2014517492 A JP 2014517492A JP 2014520767 A5 JP2014520767 A5 JP 2014520767A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- atoms
- hal
- cyc
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 7
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 6
- 125000004434 sulfur atom Chemical group 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 4
- 125000004429 atom Chemical group 0.000 claims description 3
- 125000000623 heterocyclic group Chemical group 0.000 claims description 3
- 125000002950 monocyclic group Chemical group 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 125000000815 N-oxide group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000002619 bicyclic group Chemical group 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161505376P | 2011-07-07 | 2011-07-07 | |
| US61/505,376 | 2011-07-07 | ||
| PCT/EP2012/002469 WO2013004332A1 (en) | 2011-07-07 | 2012-06-11 | Substituted azaheterocycles for the treatment of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520767A JP2014520767A (ja) | 2014-08-25 |
| JP2014520767A5 true JP2014520767A5 (cg-RX-API-DMAC7.html) | 2015-07-30 |
| JP6116554B2 JP6116554B2 (ja) | 2017-04-19 |
Family
ID=46354143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517492A Expired - Fee Related JP6116554B2 (ja) | 2011-07-07 | 2012-06-11 | がんの処置のための置換されたアザ複素環 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9199962B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2729459B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6116554B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN103649074B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012280725B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2840883C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2698847T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL230218A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013004332A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102827073A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| US9474779B2 (en) | 2012-01-19 | 2016-10-25 | Agios Pharmaceuticals, Inc. | Therapeutically active compositions and their methods of use |
| WO2014029726A1 (en) * | 2012-08-23 | 2014-02-27 | F. Hoffmann-La Roche Ag | Novel phenyl-pyridine/pyrazine amides for the treatment of cancer |
| NZ706999A (en) | 2012-10-15 | 2018-12-21 | Agios Pharmaceuticals Inc | Inhibitors of mutant isocitrate dehydrogenase and therapeutical uses thereof |
| SG11201503982XA (en) * | 2012-11-21 | 2015-06-29 | Ptc Therapeutics Inc | Substituted reverse pyrimidine bmi-1 inhibitors |
| JP2016504365A (ja) * | 2012-12-28 | 2016-02-12 | アメリカ合衆国 | Ｕｓｐ１／ｕａｆ１デユビキチナーゼ複合体阻害剤及びその使用 |
| WO2014138460A1 (en) | 2013-03-07 | 2014-09-12 | Northwestern University | 2-aminopyridine-based selective neuronal nitric oxide synthase inhibitors |
| WO2015003355A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| US9579324B2 (en) | 2013-07-11 | 2017-02-28 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| US10376510B2 (en) | 2013-07-11 | 2019-08-13 | Agios Pharmaceuticals, Inc. | 2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer |
| WO2015003360A2 (en) * | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| US20150031627A1 (en) | 2013-07-25 | 2015-01-29 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| WO2015030847A1 (en) | 2013-08-30 | 2015-03-05 | Ptc Therapeutics, Inc. | Substituted pyrimidine bmi-1 inhibitors |
| EP3626717A1 (en) | 2013-10-14 | 2020-03-25 | Eisai R&D Management Co., Ltd. | Selectively substituted quinoline compounds |
| US9663486B2 (en) | 2013-10-14 | 2017-05-30 | Eisai R&D Management Co., Ltd. | Selectively substituted quinoline compounds |
| US10584115B2 (en) | 2013-11-21 | 2020-03-10 | Ptc Therapeutics, Inc. | Substituted pyridine and pyrazine BMI-1 inhibitors |
| CN112159391A (zh) | 2014-03-14 | 2021-01-01 | 阿吉奥斯制药公司 | 治疗活性化合物的药物组合物 |
| EP3215497A4 (en) * | 2014-11-04 | 2018-11-07 | Northwestern University | Mammalian and bacterial nitric oxide synthase inhibitors |
| US10759791B2 (en) | 2014-11-04 | 2020-09-01 | Northwestern University | Mammalian and bacterial nitric oxide synthase inhibitors |
| HUE057263T2 (hu) | 2015-10-15 | 2022-04-28 | Servier Lab | Kombinációs terápia rosszindulató betegségek kezelésére |
| EP3362065B1 (en) | 2015-10-15 | 2024-04-03 | Les Laboratoires Servier | Combination therapy comprising ivosidenib, cytarabine and daunorubicin or idarubicin for treating acute myelogenous leukemia |
| ES2975690T3 (es) * | 2017-05-26 | 2024-07-11 | Cancer Research Tech Ltd | Inhibidores de BCL6 derivados de benzimidazolona |
| CN119330979A (zh) | 2018-04-13 | 2025-01-21 | 癌症研究技术有限公司 | 作为bcl6抑制剂的化合物及其制备方法 |
| US10980788B2 (en) | 2018-06-08 | 2021-04-20 | Agios Pharmaceuticals, Inc. | Therapy for treating malignancies |
| BR112021002630A2 (pt) | 2018-08-17 | 2021-05-11 | Ptc Therapeutics, Inc. | método para tratar câncer pancreático |
| US12043615B2 (en) | 2018-12-07 | 2024-07-23 | Unimatec Co., Ltd. | Fluorine-containing pyrimidine compound and method for manufacturing the same |
| TW202132285A (zh) * | 2019-11-13 | 2021-09-01 | 美商愛彼特生物製藥股份有限公司 | 經取代異吲哚啉基2,2’-聯嘧啶基化合物、其類似物及使用其之方法 |
| WO2021235420A1 (ja) | 2020-05-19 | 2021-11-25 | ユニマテック株式会社 | 含フッ素ピリミジン化合物および含フッ素ピリミジノン化合物 |
| US12213973B2 (en) | 2021-10-18 | 2025-02-04 | Northwestern University | Bacterial nitric oxide synthase inhibitors |
| JP7659651B2 (ja) | 2021-11-12 | 2025-04-09 | ユニマテック株式会社 | 含フッ素ピリミジン化合物、有害菌類防除剤および含フッ素ピリミジン化合物の製造方法 |
| CA3250418A1 (en) * | 2022-04-29 | 2025-07-08 | Asieris Pharmaceuticals (Shanghai) Co., Ltd. | PYRIMIDINE COMPOUND, ITS PREPARATION PROCESS AND PHARMACEUTICAL USE |
| WO2024094170A1 (zh) * | 2022-11-04 | 2024-05-10 | 深圳晶泰科技有限公司 | 泛素特异性蛋白酶1的抑制剂及其应用 |
| WO2025007777A1 (zh) * | 2023-07-05 | 2025-01-09 | 江苏亚虹医药科技股份有限公司 | 嘧啶类化合物、其制备方法及其医药用途 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE163647T1 (de) | 1993-08-26 | 1998-03-15 | Ono Pharmaceutical Co | 4-aminopyrimidin derivate |
| WO1996033972A1 (en) | 1995-04-28 | 1996-10-31 | Glaxo Group Limited | Methods for synthesizing diverse collections of pyridines, pyrimidines, 1,4-dihydro derivatives thereof, and piperidine derivatives |
| GB9622363D0 (en) * | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
| DK1330452T3 (da) * | 2000-09-20 | 2009-03-16 | Ortho Mcneil Janssen Pharm | Pyrazinderivater som modulatorer af tyrosinkinaser |
| WO2002047690A1 (en) * | 2000-12-12 | 2002-06-20 | Cytovia, Inc. | Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| US6716851B2 (en) * | 2000-12-12 | 2004-04-06 | Cytovia, Inc. | Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof |
| US20040102455A1 (en) * | 2001-01-30 | 2004-05-27 | Burns Christopher John | Method of inhibiting kinases |
| JP2005520821A (ja) * | 2002-03-15 | 2005-07-14 | チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド | ４−アミノピリミジン及び表面の抗菌処理のためのその使用 |
| AUPS251502A0 (en) * | 2002-05-23 | 2002-06-13 | Cytopia Pty Ltd | Protein kinase inhibitors |
| UA80767C2 (en) * | 2002-12-20 | 2007-10-25 | Pfizer Prod Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
| US7459460B2 (en) * | 2003-05-28 | 2008-12-02 | Bristol-Myers Squibb Company | Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators |
| US7816529B2 (en) * | 2003-07-02 | 2010-10-19 | Vertex Pharmaceuticals Incorporated | Pyrimidines useful as modulators of voltage-gated ion channels |
| JP5319113B2 (ja) * | 2004-03-26 | 2013-10-16 | メチルジーン インコーポレイテッド | ヒストンデアセチラーゼの阻害剤 |
| US7253204B2 (en) * | 2004-03-26 | 2007-08-07 | Methylgene Inc. | Inhibitors of histone deacetylase |
| WO2007008541A2 (en) * | 2005-07-08 | 2007-01-18 | Kalypsys, Inc. | Cellular cholesterol absorption modifiers |
| CN101730703B (zh) | 2007-03-16 | 2012-12-26 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 具有抗增殖活性的苯甲酰胺类衍生物及其药用制剂 |
| CN101778825A (zh) | 2007-03-22 | 2010-07-14 | 沃泰克斯药物股份有限公司 | 适用作詹纳斯激酶抑制剂的n-杂环类化合物 |
| US20090048282A1 (en) | 2007-08-14 | 2009-02-19 | Wyeth | Pyrimidine sulfonamide analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| WO2009027736A2 (en) * | 2007-08-27 | 2009-03-05 | Astrazeneca Ab | 2,4 diaminopyrimid'lnes for the treatment of myeloproliferative disorders and cancer |
| WO2009039542A2 (en) | 2007-09-24 | 2009-04-02 | Fibrex Medical Research & Development Gmbh | Methods of screening for compounds having anti- inflammatory activity and/or prevent / treat vascular leak |
| JP2010126496A (ja) * | 2008-11-28 | 2010-06-10 | Mitsubishi Tanabe Pharma Corp | 複素環化合物 |
| ES2453474T3 (es) * | 2009-02-06 | 2014-04-07 | Nippon Shinyaku Co., Ltd. | Derivados de aminopirazina y medicamento correspondiente |
| WO2010126922A1 (en) | 2009-04-30 | 2010-11-04 | Glaxosmithkline Llc | Benzimidazolecarboxamides as inhibitors of fak |
| TW201100441A (en) | 2009-06-01 | 2011-01-01 | Osi Pharm Inc | Amino pyrimidine anticancer compounds |
| WO2013066839A2 (en) * | 2011-10-31 | 2013-05-10 | Glaxosmithkline Llc | Compounds and methods |
-
2012
- 2012-06-11 AU AU2012280725A patent/AU2012280725B2/en not_active Ceased
- 2012-06-11 US US14/131,309 patent/US9199962B2/en not_active Expired - Fee Related
- 2012-06-11 JP JP2014517492A patent/JP6116554B2/ja not_active Expired - Fee Related
- 2012-06-11 CA CA2840883A patent/CA2840883C/en not_active Expired - Fee Related
- 2012-06-11 WO PCT/EP2012/002469 patent/WO2013004332A1/en not_active Ceased
- 2012-06-11 CN CN201280033808.9A patent/CN103649074B/zh not_active Expired - Fee Related
- 2012-06-11 ES ES12729352T patent/ES2698847T3/es active Active
- 2012-06-11 EP EP12729352.0A patent/EP2729459B1/en not_active Not-in-force
-
2013
- 2013-12-29 IL IL230218A patent/IL230218A/en active IP Right Grant